Neoplasms

Respiratory Tract (Lung and Bronchial) Diseases

All Conditions

Infections

Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Mycobacterium Infections

Carcinoma

Respiratory Tract Neoplasms

Thoracic Neoplasms

Lung Diseases

Respiratory Tract Diseases

Carcinoma, Bronchogenic

Bronchial Neoplasms

Antineoplastic Agents

All Drugs and Chemicals

Paclitaxel

Albumin-Bound Paclitaxel

Cisplatin

Immunomodulating Agents

Adjuvants, Immunologic

Tubulin Modulators

Antimitotic Agents

Paclitaxel & Cisplatin

Mycobacterium w.

R K Chaudhary, MD

Rajeev Gupta, MD

Anup Majumdar, MD

A. Rajkumar, MD

Rajeev Seam, MD

A.K. Patel, MD

Chanchal Goswami, MD

Jaydip Biswas, MD

Ritwik Pandyea, MD

Aloke G Dastidar, MD

Narayanankutty Warrier, MD

Ashutosh N Aggarwal, MD

Apurva Patel, MD

Santanu Chaudhary, MD

Rajeev Prasad, MD

Ramakrishna Malladi, MD

The purpose of this study is to determine whether Mycobacterium w in combination with Paclitaxel plus Cisplatin are effective in Advanced Non Small Cell Lung cancer.

Non-small cell lung cancer (NSCLC) accounts for 75% of all lung cancers. majority of patients of NSCLC patients are stage IIIA or IIIB patients are suitable for radiotherapy, which could not improve the survival rates of 5-10%. This study proposed Mycobacterium w (heat killed) in combination chemotherapy of Cisplatin and Paclitaxel along with radiotherapy for adjuvant therapy management of NSCLC in controlled clinical trial, which may prove the efficacy, better survival rate and quality of life.

A Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung Cancer

Open Label, Randomized Multicentric Phase II Clinical Trial of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin Versus Paclitaxel and Cisplatin in Advanced Non Small Cell Lung Cancer.

Cadila Pharnmaceuticals

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
A Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung Cancer	NCT00680940	Non Small Cell ...	Paclitaxel & Ci... Mycobacterium w...	18 Years -	Cadila Pharnmaceuticals
A Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung Cancer	NCT00680940	Non Small Cell ...	Paclitaxel & Ci... Mycobacterium w...	18 Years -	Cadila Pharnmaceuticals

Spots Global Cancer Trial Database for paclitaxel & cisplatin